As a Managing Director of Environmental, Social and Governance (ESG) sustainability at Stern Investor Relations, a Precision Medical Group (PMG) company, Molly provides innovative public and private biomedical firms with industry-leading ESG advising and services. Pairing Stern IR’s deep knowledge of the investment landscape with PMG’s premier biotechnology and pharma industry exposure, Dr. Podolefsky’s ESG team offers a tailored approach to ESG, maximizing return on investment for firms in the biomed industry. Molly leads a team of skilled investor relations and ESG professionals dedicated to helping biomed firms define and manage material sustainability issues while leveraging ESG as a tool for value creation. From attracting sustainably-motivated investment dollars, to unlocking lower costs of capital, Dr. Podolefsky helps cutting edge biotechnology firms solving today’s healthcare challenges survive and thrive in a competitive landscape while satisfying increasing demands for sustainability.
Before joining Stern IR, Molly led global ESG solutions for Guidehouse, a global consulting firm, working with public and private companies across the health, biotech, private equity, real-estate, energy, fashion, food and beverage and consumer goods industries to develop and launch robust, research-based ESG programs. Dr. Podolefsky earned her Ph.D. in Economics from the University of Colorado at Boulder, and leverages her deep expertise in behavioral science, consumer behavior, energy efficiency, renewable energy and natural resource conservation to help firms develop holistic, business-oriented approaches to ESG. A lifelong advocate of DEI and women’s leadership, Dr. Podolefsky contributes to thought leadership and remains actively engaged in diversity and inclusion both within her firm, community and industry.